Case Study: Glaxo Smith Kline Overview The pharmaceutical industry is well known for the enormous research and development costs needed to produce innovations that become new treatments. Analyzing the financial returns associated with such investments is more important than ever to quantify and qualify. It is important for GSK to select reliable database technologies. The Client Glaxo Smith Kline, one of the world's leading research-based pharmaceutical and healthcare companies, selected ITTIA's database technology for improving its cost- savings and financial decision support tools. ITTIA technology provides access to important data used to analyze investment returns. The Challenge Technology investments are critical to an organization's ability to produce a quality pipeline of prod

Join for free to read